What CalciMedica Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 0 |
| Total trades | 0 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 3,859,074 |
| Disposed | 0 | 0 |
| Net activity | +0 | +3,859,074 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Jun 25 | Grant / award · A | +186,729 | $0.80 | +$150K | 317,655 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Jun 25 | Grant / award · A | +186,729 | $0.80 | +$150K | 366,435 |
| Middleton Fred A | Director | Jun 25 | Open-market buy · P | +248,972 | $0.80 | +$200K | 1,063,272 |
| Hebbar Sudarshan | Chief Medical Officer | Jun 25 | Grant / award · A | +124,486 | $0.80 | +$100K | 186,025 |
| Wilson Robert N | Director | Jun 25 | Grant / award · A | +1,182,621 | $0.80 | +$950K | 1,604,650 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Sep 18 | Open-market buy · P | +2,500 | $3.07 | +$7.68K | 84,150 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Sep 15 | Open-market buy · P | +3,400 | $2.68 | +$9.1K | 81,650 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Sep 12 | Open-market buy · P | +5,000 | $3.12 | +$15.6K | 78,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Sep 09 | Open-market buy · P | +2,343 | $3.15 | +$7.38K | 73,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 29 | Open-market buy · P | +800 | $2.74 | +$2.19K | 70,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 28 | Open-market buy · P | +9,200 | $2.86 | +$26.3K | 70,107 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 21 | Open-market buy · P | +3,508 | $2.79 | +$9.8K | 60,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 20 | Exercise / conversion · M | +15,000 | $1.53 | +$23K | 179,706 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 20 | Open-market buy · P | +2,000 | $2.72 | +$5.44K | 57,399 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 19 | Open-market buy · P | +9,563 | $2.82 | +$27K | 61,539 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 19 | Open-market buy · P | +1,000 | $2.79 | +$2.79K | 55,399 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 15 | Open-market buy · P | +4,392 | $2.79 | +$12.3K | 51,976 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | Aug 15 | Open-market buy · P | +5,076 | $2.90 | +$14.7K | 54,399 |
| Hebbar Sudarshan | Chief Medical Officer | Aug 14 | Open-market buy · P | +1,584 | $2.59 | +$4.09K | 47,584 |
| Stauderman Kenneth A. | Chief Scientific Officer | Jul 28 | Open-market buy · P | +1,000 | $3.96 | +$3.96K | 12,944 |
Loading...